The Pfizer Applied Clinical Pharmacology Program is a multi-year program created by Applied Pharmaceutical Innovation (API) in partnership with the Faculty of Pharmacy and Pharmaceutical Sciences (FoPPS) at University of Alberta with support from members of the Global Clinical Pharmacology team at Pfizer. The program aims to strengthen development and learning opportunities for students interested in the industry applications of pharmacokinetics, including advanced modeling, as well as the regulatory pathway of drugs.
Edmonton, AB. March 16, 2022: Applied Pharmaceutical Innovation, the University of Alberta and members from Pfizer’s Global Clinical Pharmacology team today announced the launch of the Pfizer Applied Clinical Pharmacology Program to enhance job-ready programing available to students in the pharmaceutical sciences who will be able to pursue new opportunities as clinical pharmacologists, regulatory affairs professionals, pharmacometricians, and more in the global life sciences industry.
Through this collaboration, members of Pfizer’s global clinical pharmacology team, including API’s Scientific Advisor and Faculty of Pharmacy and Pharmaceutical Sciences (FoPPS) alumnus, Brian Corrigan, will work closely with academic experts from FoPPS and API’s industry experts to design a unique curriculum with expanded offerings in pharmacokinetics, biostatistics, clinical pharmacology, drug development and regulatory affairs.
“There is a strong legacy of excellence at the U of A in the pharmaceutical sciences, and to have a collaboration like this speaks volumes to our ability to leverage that excellence tackling real word problems in the pharmaceutical industry,” says Andrew MacIsaac, CEO, API. “We are thrilled to be working with Pfizer and the University of Alberta to ensure that our talented student leaders have access and funding to broaden their expertise while learning from global leaders in the field.”
“The Faculty of Pharmacy and Pharmaceutical Sciences remains at the forefront of educating students to lead real-world drug development and research thanks in large part to our industry partners’ dedication to building strong foundations of support for our students,” says Christine Hughes, interim dean, FoPPS. “With opportunities and partnerships like these we continue to provide our students with enriched learning experiences leading to impactful and focused career paths.”
“As supporters of the program, we will be active participants by providing guest lecturers to the University, and fellowships for students to work with us at Pfizer,” says Brian Corrigan, Global Head, Clinical Pharmacology, Pfizer and member of API’s Scientific Advisory Committee. “Through this partnership, Pfizer, UAlberta and API will work together to harness the talent and potential that exists in Canada to help develop the next generation of leaders in clinical pharmacology.”
More information here.
For any media queries, please contact email@example.com.